Cargando…
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia
SIMPLE SUMMARY: Chronic lymphocytic leukaemia (CLL) is the most frequent type of leukaemia with a highly variable presentation, clinical course, and outcome. The overall aim of our study was to determine the clinical and functional significance of two B-cell regulators, BACH2 and BCL6, in CLL. The r...
Autores principales: | Ciardullo, Carmela, Szoltysek, Katarzyna, Zhou, Peixun, Pietrowska, Monika, Marczak, Lukasz, Willmore, Elaine, Enshaei, Amir, Walaszczyk, Anna, Ho, Jia Yee, Rand, Vikki, Marshall, Scott, Hall, Andrew G., Harrison, Christine J., Soundararajan, Meera, Eswaran, Jeyanthy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750551/ https://www.ncbi.nlm.nih.gov/pubmed/35008187 http://dx.doi.org/10.3390/cancers14010023 |
Ejemplares similares
-
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia
por: Szoltysek, Katarzyna, et al.
Publicado: (2020) -
Human Miro Proteins Act as NTP Hydrolases through a Novel, Non-Canonical Catalytic Mechanism
por: Peters, Daniel T., et al.
Publicado: (2018) -
Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from Malaysia
por: Ambayya, Angeli, et al.
Publicado: (2021) -
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition
por: Aptullahoglu, Erhan, et al.
Publicado: (2023) -
Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
por: Sinclair, Paul B., et al.
Publicado: (2023)